Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-27T19:54:06.278Z Has data issue: false hasContentIssue false
  • English
  • Français

Le SARM, en pleine forme et florissant au Canada. Que peut bien faire un médecin d'urgence?

Published online by Cambridge University Press:  21 May 2015

Heather Murray
Heather Murray*
Affiliation:
Professeure agrégée, Départements de médecine et de santé communautaire et d'épidémiologie, Université Queen's, Kingston (Ontario)
*
Département de médecine d’urgence, Université Queen’s, 76, rue Stuart, Kingston ON K7L 2V7; télécopieur : 613 548–1374; [email protected]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

Staphylococcus aureusrésistance à la méthicillineinfections à origine communautaireinfections de la peauinfections des tissus mous
Type
Editorials • Éditoriaux
Information
Canadian Journal of Emergency Medicine , Volume 11 , Issue 5 , September 2009 , pp. 420 - 423
Copyright
Copyright © Canadian Association of Emergency Physicians 2009

References

RÉFÉRENCES

1.Stenstrom, R, Grafstein, E, Romney, M, et coll. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus skin and soft tissue infection in a Canadian emergency department. JCMU 2009;11:430–8.Google Scholar
2.Adam, HJ, Allen, VG, Currie, A, et coll. Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors. JCMU 2009;11:439–46.Google Scholar
3.Moran, GJ, Krishnadasan, A, Gorwitz, RJ, et coll. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666–74.Google Scholar
4.Boucher, HW, Corey, GR. Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008;46(Suppl 5):S344–9.Google Scholar
5.Seybold, U, Kourbatova, EV, Johnson, JG, et coll. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647–56.Google Scholar
6.Gillet, Y, Issartel, B, Vanhems, P, et coll. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;359:753–9.Google Scholar
7.Hageman, JC, Uyeki, TM, Francis, JS, et coll. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003–04 influenza season. Emerg Infect Dis 2006;12:894–9.Google Scholar
8.Fridkin, SK, Hageman, JC, Morrison, M, et coll. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436–44.Google Scholar
9.Lee, MC, Rios, AM, Aten, MF, et coll. Management and outcome of children with skin and soft tissue abscesses cause by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004;23:123–7.Google Scholar
10.Rajendran, PM, Young, D, Mauer, T, et coll. Randomized, double-blind, placebo controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2007;51:4044–8.Google Scholar
11.Hammond, SP, Baden, LR. Management of skin and soft-tissue infection — polling results. N Engl J Med 2008;359:e20.Google Scholar
12.Patrick, DM, Hutchinson, J. Antibiotic use and population ecology: How you can reduce your “resistance footprint.” JAMC 2009;180:416–21.Google Scholar